{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P26718",
      "entity_text" : "NKG2D",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0924" ],
      "CellLine" : [ "cellosaurus:CVCL_2142" ],
      "Organ" : [ "uberon:UBERON:0001092" ],
      "Species" : [ "taxonomy:9606" ],
      "CellType" : [ "cl:CL:0000623" ]
    }
  },
  "verbose_text" : "Taken together with our observation of decreased DNAM-1 and NKG2D expression on tumor infiltrating NK cells in sarcoma and the enhanced cytotoxic activity of NK-92 cells expressing DNAM-1 or NKG2D against sarcoma explants, these results put forward DNAM-1- or NKG2D based immunotherapy as a potentially effective approach in sarcoma treatment.",
  "reading_complete" : "2020-08-04T13:01:12Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T12:56:49Z",
  "trigger" : "expression",
  "evidence" : [ "NKG2D expression" ],
  "pmc_id" : "7001093",
  "score" : 0
}